Modern approaches to the diagnosis and treatment of patients with non-muscle-invasive bladder cancer

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review article discusses modern methods for diagnosing and treating patients with non-muscle-invasive bladder cancer. The search and analysis of information was carried out in the databases PubMed, Google Scholar, eLibrary. Information about photodynamic diagnostics, narrow-band imaging, mono- and bipolar transurethral resection, transurethral thulium and holmium laser resection, en-bloc resection of neoplasms, Nd:YAG laser ablation of the tumor bed is presented. The features, advantages and disadvantages of each of these methods, as well as their combinations and modifications are described in detail. Particular attention is paid to the use of laser technologies in the surgical treatment of patients with non-muscle-invasive bladder cancer. An analysis of the results of studies of the efficacy and safety of various methods of surgical treatment of non-muscle-invasive bladder cancer was carried out. The significance of the problem of increasing the efficiency of treatment of such patients, which is one of the priority areas of modern oncourology, is indicated.

Full Text

Restricted Access

About the authors

Alexander S. Babkin

Russian Medical Academy of Continuous Professional Education; City Clinical Hospital No. 13

Author for correspondence.
Email: alexbabkin3004@mail.ru
ORCID iD: 0000-0003-1570-1793

postgraduate student, urologist

Russian Federation, Moscow; Moscow

Oleg V. Teodorovich

Russian Medical Academy of Continuous Professional Education

Email: teoclinic@gmail.co
ORCID iD: 0000-0002-5145-0445
SPIN-code: 1835-4808

Dr. Sci. (Med.), professor, head at the Department of Endoscopic Urology

Russian Federation, Moscow

Suleyman I. Suleymanov

City Clinical Hospital No. 13

Email: s.i.suleymanov@mail.ru
ORCID iD: 0000-0002-0461-9885
SPIN-code: 7168-8819

MD, Dr. Sci. (Med.), head of the Urology Department

Russian Federation, Moscow

Maksim N. Shatokhin

Russian Medical Academy of Continuous Professional Education

Email: sh.77@mail.ru
ORCID iD: 0000-0002-1285-7357
SPIN-code: 7344-9309

Dr. Sci. (Med.), professor of the Department of Endoscopic Urology

Russian Federation, Moscow

Gennadij G. Borisenko

Russian Medical Academy of Continuous Professional Education

Email: gborisenko-doc@mail.ru

Cand. Sci. (Med.), assistant professor of the Department of Endoscopic Urology

Russian Federation, Moscow

Elena V. Rasshchupkina

Russian Medical Academy of Continuous Professional Education

Email: rashupkinaev@rmapo.ru

Cand. Sci. (Med), assistant of the Department of Endoscopic Urology

Russian Federation, Moscow

References

  1. Weijers Y, Arentsen HC, Arends TJ, Witjes JA. Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma. Hematol Oncol Clin North Am. 2015;29(2):219–225. doi: 10.1016/j.hoc.2014.11.001
  2. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387. doi: 10.1016/j.ejca.2018.07.005
  3. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN2012. Int J Cancer. 2015;136(5):E359–E386. doi: 10.1002/ijc.29210
  4. Kaprin AD, Starinskii VV, Shakhzadova AO. Zlokachestvennye novoobrazovaniya v Rossii v 2021 godu (zabolevaemost’ i smertnost’). Moscow: FGBU “MNIOI im. P.A. Gertsena” Minzdrava Rossii, 2022. 252 p. (In Russ.)
  5. Chavan S, Bray F, Lortet-Tieulent J, et al. International variations in bladder cancer incidence and mortality. Eur Urol. 2014;66(1):59–73. doi: 10.1016/j.eururo.2013.10.001
  6. Moyer VA. Screening for bladder cancer: U.S. Preventive Services task force recommendation statement. Ann Intern Med. 2011;155(4): 246–251. doi: 10.7326/0003-4819-155-4-201108160-00008
  7. Burger M, Catto JWF, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–241. doi: 10.1016/j.eururo.2012.07.033
  8. Calderone C, Taylor JM. Urothelial cancer of the bladder: treatment of early stage disease. Abdominal Key. 2017;157:24.
  9. Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, et al. Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. J Urol. 2010;183(3):915–920. doi: 10.1016/j.juro.2009.11.018
  10. Ramirez D, Gupta A, Canter D, et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117(5):783–786. doi: 10.1111/bju.13345
  11. Yafi FA, Brimo F, Steinberg J, et al. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015;33(2):66.e25–66e.31. doi: 10.1016/j.urolonc.2014.06.008
  12. Krajewski W, Kościelska-Kasprzak K, Rymaszewska J, Zdrojowy R. How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial. Qual Life Res. 2017;26(3):625–634. doi: 10.1007/s11136-016-1493-1
  13. DeGeorge KC, Holt HR, Hodges SC. Bladder cancer: Diagnosis and treatment. Am Fam Physician. 2017;96(8):507–514.
  14. Choyke PL. Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria. Am Fam Physician. 2008;78(3):347–352.
  15. Huang L, Kong Q, Liu Z, et al. The diagnostic value of MR imaging in differentiating T staging of bladder cancer: A meta-analysis. Radiology. 2018;286(2):502–511. doi: 10.1148/radiol.2017171028
  16. Palou J, Rodríguez-Rubio F, Huguet J, et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol. 2005;174(3):859–861. doi: 10.1097/01.ju.0000169424.79702.6d
  17. Vind-Kezunovic S, Bouchelouche K, Ipsen P, et al. Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and 18f-fluorodeoxyglucose positron emission tomography/computed tomography: Results from a high-volume centre including long-term follow-up. Eur Urol Focus. 2019;5(1):90–96. doi: 10.1016/j.euf.2017.06.005
  18. Palou J, Pisano F, Sylvester R, et al. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World J Urol. 2018;36(10):1621–1627. doi: 10.1007/s00345-018-2299-2
  19. Burger M, Grossman HB, Droller M, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013;64(5):846–854. doi: 10.1016/j.eururo.2013.03.059
  20. Jocham D, Witjes F, Wagner S, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174(3):862–866. doi: 10.1097/01.ju.0000169257.19841.2a
  21. Stenzl A, Burger M, Fradet Y, et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010;184(5):1907–1913. doi: 10.1016/j.juro.2010.06.148
  22. Hermann GG, Mogensen K, Carlsson S, et al. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. BJU Int. 2011;108(8b): E297–E303. doi: 10.1111/j.1464-410X.2011.10090.x
  23. Li K, Lin T, Fan X, et al. Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Urol. 2013;20(6):602–609. doi: 10.1111/j.1442-2042.2012.03211.x
  24. Venkatramani V, Panda A, Manojkumar R, Kekre NS. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol. 2014;191(6):1703–1707. doi: 10.1016/j.juro.2013.12.004
  25. Wang DS, Bird VG, Leonard VY, et al. Use of bipolar energy for transurethral resection of bladder tumors: pathologic considerations. J Endourol. 2004;18(6):578–582. doi: 10.1089/end.2004.18.578
  26. Zhao C, Tang K, Yang H, et al. Bipolar versus monopolar transurethral resection of nonmuscle-invasive bladder cancer: A meta-analysis. J Endourol. 2016;30(1):5–12. doi: 10.1089/end.2015.0410
  27. Pradhan M, Gnyawali D. MP49–13 safety and efficacy of monopolar vs bipolar transurethral resection of bladder tumor. J Urol. 2020;203(S4): e746–e746. doi: 10.1097/JU.0000000000000911.013
  28. Ukai R, Kawashita E, Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol. 2000;163(3):878–879. doi: 10.1016/S0022-5347(05)67824-X
  29. Naselli A, Puppo P. En Bloc Transurethral resection of bladder tumors: A new standard? J Endourol. 2017;31(S1):S20–S24. doi: 10.1089/end.2016.0534
  30. Grimberg DC, Shah A, Inman BA. En bloc resection of bladder tumors: Style or substance? Eur Urol. 2020;78(4):570–571. doi: 10.1016/j.eururo.2020.05.019
  31. Wu Y-P, Lin T-T, Chen S-H, et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis. Medicine (Baltimore). 2016;95(45):e5372. doi: 10.1097/MD.0000000000005372
  32. Sureka SK, Agarwal V, Agnihotri S, et al. Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression? A prospective study. Indian J Urol. 2014;30(2):144–149. doi: 10.4103/0970-1591.126887
  33. Kislyakov DA, Severgina LO, Tsarichenko DG, et al. Novel approaches for transurethral en-bloc resection of large bladder tumors. Urologiia. 2019;(4):105–111. (In Russ.) doi: 10.18565/urology.2019.4.105-111
  34. Enikeev D, Shariat SF. Novel technologies that change the diagnostic and treatment paradigm in urology: En-bloc as the new treatment standard. Curr Opin Urol. 2020;30(3):475–476. doi: 10.1097/mou.0000000000000747
  35. Kamalov AA, Sorokin NI, Dymov AM, et al. Technical aspects of laser en bloc resection of the bladder tumor for non-muscle-invasive bladder cancer. Surgical practice. 2020;(1):53–58. (In Russ.) doi: 10.38181/2223-2427-2020-1-53-58
  36. Laukhtina EA, Shpikina AD, Taratkin MS, et al. The efficacy and safety of EN BLOC resection in non-muscle-invasive bladder cancer. Urology and Andrology. 2020;8(1): 26–39. (In Russ.) doi: 10.20953/2307-6631-2020-1-26-39
  37. Sorokin NI, Enikeev DV, Dymov AM, et al. Safety and efficacy of thulium transurethral en block resection with fiber laser “Urоlaz” for treatment of non-muscle-invasive bladder cancer. Cancer Urology. 2018;14(1): 144–151. (In Russ.) doi: 10.17650/1726-9776-2018-14-1-144-151
  38. Enikeev D, Babjuk M, Shpikina A, et al. En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser. Curr Opin Urol. 2022;32(2):173–178. doi: 10.1097/MOU.0000000000000968
  39. Cho Y-H, Chi S-C, Hernanadez AD, et al. Adriamycin absorption after Nd: YAG laser coagulation compared to electrosurgical resection of the bladder wall. J Urol. 1992;147(4):1139–1141. doi: 10.1016/s0022-5347(17)37503-1
  40. Bai Y, Liu L, Yuan H, et al. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis. World J Surg Oncol. 2014;12:301. doi: 10.1186/1477-7819-12-301
  41. Yang H, Wang N, Han S, et al. Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis. Lasers Med Sci. 2017;32(9):2005–2012. doi: 10.1007/s10103-017-2308-5
  42. Wang W, Liu H, Xia S. Thulium laser treatment for bladder cancer. Asian J Urol. 2016;3(3):130–133. doi: 10.1016/j.ajur.2016.05.002
  43. Herrmann TR, Liatsikos EN, Nagele U, et al. EAU guidelines on laser technologies. Eur Urol. 2012;61(4):783–795. doi: 10.1016/j.eururo.2012.01.010
  44. Gao X, Ren S, Xu C, Sun Y. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience. BJU Int. 2008;102(9):1115–1118. doi: 10.1111/j.1464-410X.2008.07814.x
  45. Wolters M, Kramer MW, Becker JU, et al. Tm: YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol. 2011;29(4):429–432. doi: 10.1007/s00345-011-0686-z
  46. Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol. 2006;49(6):961–969. doi: 10.1016/j.eururo.2006.03.028
  47. Koca O, Keleş MO, Kaya C, et al. Plasmakinetic vaporization versus transurethral resection of the prostate: Six-year results. Turk J Urol. 2014;40(3):134–137. doi: 10.5152/tud.2014.82195
  48. Iscaife A, Ribeiro Filho LA, Aparecido Pereira MWA, et al. Holmium laser resection of large bladder tumors: Technique description, feasibility, and histopathological quality analysis. Urology. 2022;165:373. doi: 10.1016/j.urology.2022.04.021
  49. Gupta NP, Saini AK, Dogra PN, et al. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience. BJU Int. 2011;108(4):553–556. doi: 10.1111/j.1464-410X.2010.09903.x
  50. Gravas S, Bachmann A, Reich O, et al. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011;107(7):1030–1043. doi: 10.1111/j.1464-410X.2010.09954.x
  51. Chen C-H, Chiang P-H, Chuang Y-C, et al. Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology. 2010;75(3):658–663. doi: 10.1016/j.urology.2009.09.033
  52. Teichmann H-O, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol. 2007;25(3):221–225. doi: 10.1007/s00345-007-0184-5
  53. Rasshupkina EV, Teodorovich OV, Kochiev DG, et al. Experimental validation of ND: YAG laser coagulation of the bladder tissue. Urologiia. 2015;(3):55–59. (In Russ.)
  54. Borota AV, Konopko AV, Anishchenko AA, et al. Sposoby khirurgicheskogo lecheniya invazivnogo raka mochevogo puzyrya (obzor literatury). Novoobrazovanie. 2010;(2):24–35. (In Russ.)
  55. Dołowy Ł, Krajewski W, Dembowski J, et al. The role of lasers in modern urology. Cent European J Urol. 2015;68(2):175–182. doi: 10.5173/ceju.2015.53
  56. Heinrich E, Wendt-Nordahl G, Honeck P, et al. 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol. 2010;24(1):75–79. doi: 10.1089/end.2009.0051
  57. Teodorovich OV, Shatokhin MN, Abdullaev MI, et al. Interstitial laser coagulation in the management of urothelial papillary carcinoma of the renal pelvis. Urologiia. 2018;(4):122–126. (In Russ.) doi: 10.18565/urology.2018.4.122-126

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ №ФС77-65570 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies